Donor lymphocyte infusion, both alone and in combination with azacitidine, restored CD34 levels in two-thirds of patients with a baseline CD34 donor chimerism of less than 80%. Researchers confirmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results